Connection

Roy Gulick to Reverse Transcriptase Inhibitors

Back to Details
This is a "connection" page, showing publications Roy Gulick has written about Reverse Transcriptase Inhibitors.
Roy Gulick
Connection Strength
0.407
Reverse Transcriptase Inhibitors
  1. Durability of response to treatment among antiretroviral-experienced subjects: 48-week results from AIDS Clinical Trials Group Protocol 359. J Infect Dis. 2002 Sep 01; 186(5):626-33.
    View in: PubMed
    Score: 0.211
  2. Investigational Antiretroviral Drugs: What is Coming Down the Pipeline. Top Antivir Med. 2018 Apr; 25(4):127-132.
    View in: PubMed
    Score: 0.156
  3. Brain neurotransmitter transporter/receptor genomics and efavirenz central nervous system adverse events. Pharmacogenet Genomics. 2018 07; 28(7):179-187.
    View in: PubMed
    Score: 0.040
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.